| Old Articles: <Older 12391-12400 Newer> |
 |
The Motley Fool February 13, 2006 John Bluis |
More of the Same for Panera The eatery again saw more than 30% growth in revenues, impressive same-store sales, and a whole lot of new stores.  |
The Motley Fool February 13, 2006 Alyce Lomax |
Chantico and Coffee Don't Mix? Say it isn't so -- Starbucks flubs a drink. Should investors worry?  |
The Motley Fool February 13, 2006 Stephen D. Simpson |
Symyx's Formula for Success: Wait The sizzle of this chemical research expediter is enticing, but be careful not to get burned -- this stock has been pretty volatile over time.  |
The Motley Fool February 13, 2006 Rich Smith |
Foolish Forecast: Abercrombie on the Catwalk Unless there is a reversal of the inventory trend, this is an awfully good time for investors to start getting nervous about Abercrombie.  |
The Motley Fool February 13, 2006 Alyce Lomax |
Tech Firms in the Hot Seat Technology and Internet companies' dealings with China, where free speech on the Internet is extremely limited, have drawn congressional human rights scrutiny. What does it mean to shareholders?  |
The Motley Fool February 13, 2006 Stephen D. Simpson |
Will Anadarko Measure Up? Anadarko may be a relative value, but other energy stocks look better.  |
The Motley Fool February 13, 2006 Stephen D. Simpson |
An Electric Quarter for Emerson Has price outstripped value for this conglomerate? Investors, take note.  |
The Motley Fool February 13, 2006 Stephen D. Simpson |
Win, Lose, or Nam Tai The Chinese electronics assembler is still winning the race between revenue growth and margin deterioration. However, there are a couple of oddities here that investors should pay attention to.  |
The Motley Fool February 13, 2006 Stephen D. Simpson |
ResMed Might Need Oxygen Like its cousin Respironics, this company suffers from an all-too-common fate in med-tech land: It's a great company trading at a not-so-great price.  |
The Motley Fool February 13, 2006 Stephen D. Simpson |
Agilent Still Measures Up Management has gradually carved Agilent into a well-run player in the measurement and test markets. Will the stock continue to measure up for its owners?  |
| <Older 12391-12400 Newer> Return to current articles. |